Church & Dwight Co Inc (CHD)
Juste valeurFondamental
67
Prix
$94.00
Capitalisation boursière
$22.68B
Partie 1 · Ce que vaut l'entreprise
Vue d'ensemble
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers baking soda, cat litters, laundry detergents, carpet deodorizers, and other baking soda-based products under the ARM & HAMMER brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; dry shampoos under the BATISTE brand; water flossers under the WATERPIK brand; oral care products under the THERABREATH brand; acne treatment products under the HERO brand; hand sanitizers under the TOUCHLAND brand; and condoms, lubricants, and vibrators under the TROJAN brand. It also provides home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; and cold shortening and relief products under the ZICAM brand. In addition, the company's specialty products include animal and food productivity products, such as ARM & HAMMER baking soda as a feed additive to help dairy cow; BIO-CHLOR and FERMENTEN used to reduce health issues associated with calving, as well as needed protein; CELMANAX refined functional carbohydrate, a yeast-based prebiotic; and CERTILLUS a probiotics products used in the poultry, dairy, beef, and swine industries. Additionally, it offers sodium bicarbonate; and cleaning and deodorizing products. The company sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. Church & Dwight Co., Inc. was founded in 1846 and is headquartered in Ewing, New Jersey.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 18 septembre 2026 with claude-haiku-4-5 — shared with all users
P&G is the first competitor named in Church & Dwight's own 10-K and fights for the same US shelf space in laundry detergent (Tide versus Arm & Hammer and Xtra), oral care and personal care.
Clorox is the closest rival by size and profile, competing on the same US household aisle in laundry additives, cleaners and cat litter (Fresh Step versus Arm & Hammer).
Colgate-Palmolive competes head-on in oral care against Arm & Hammer toothpaste, Spinbrush and TheraBreath, and in home care and pet products sold through the same retailers.
Kenvue competes in consumer self-care, where its Listerine, Neutrogena and cold-and-allergy brands sit against TheraBreath, Hero acne treatment and Zicam.
Reckitt competes across cleaning and health-and-hygiene categories where Church & Dwight also sells, from surface cleaners to sexual wellness products rivaling Trojan.
Unilever competes in personal care and home care worldwide, with dry shampoo, deodorant and laundry brands aimed at the same shoppers as Batiste and Arm & Hammer.
Bilan & Liquidités
Chiffre d'affaires
$6.23B
12 derniers mois (au 30/06/2026)
Résultat net
$745M
12 derniers mois (au 30/06/2026)
Flux de trésorerie libre
$1.09B
Capitaux propres totaux
$4.00B
Passif total
$4.91B
Ratio de liquidité général
1.15
Couverture des intérêts
11.26
Dette/EBITDA
1.87
Bénéfice par action
Chiffre d'affaires & Résultat net
Flux de trésorerie libre
Décomposition du résultat
État historique
Marges dans le temps
La dette dans le temps
Le poids de la dette
Grille de la croissance
Croissance — Chiffre d'affaires
Estimation de la juste valeur
Juste valeur
$80.51
Prix actuel
$94.00
Marge de sécurité
-16.8%
Fourchette de juste valeur
$56.29 - $104.72
Écart entre les méthodes de valorisation utilisées, pas un intervalle de confiance calibré statistiquement.
Méthodes d'estimation
Indicateurs de valorisation
Ratio P/E
30.30
ROE
18.4%
Ratio P/B
5.14
P/FCF
20.75
Marge brute
45.6%
ROIC
11.1%
Radar de rentabilité
Création de valeur (avantage concurrentiel)
ROIC
11.1%
WACC
7.5%
ROIC − WACC
+3.5 pp
Le ROIC dépasse le coût du capital — l'entreprise crée de la valeur pour les actionnaires.
Critères d'analyse fondamentale
Réussi (19)
- EPS shows upward trend
- Price CAGR 7.86%
- ROIC 11.0%
- Gross Margin 45.6%
- P/FCF 20.75
- Debt/Equity ratio
- Operating Margin 17.5%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 17.8%
- Analyst Consensus 50% Buy
- Earnings Quality (OCF/NI) 1.65
- Share Dilution -1.2%
- Net Margin Trend 12.0% vs 8.7%
- Piotroski F-Score 6/9
Échoué (7)
- EPS CAGR 0.49%
- P/B Ratio 5.14
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Revenue Growth 5Y 4.8%
- Earnings Surprise avg 2.5%
Indisponible (2)
- Dividend Payout NaN%
- PEG Ratio (need PE > 0 and growth > 0)
Score F de Piotroski
Signaux mixtes : certains domaines nécessitent attention
Qualité des bénéfices
Qualité élevée : bénéfices soutenus par la trésorerie
Dilution du capital
Rachat d'actions. Favorable aux actionnaires
Participations institutionnelles
Gouvernance
Équipe dirigeante
| Nom | Titre | Âge |
|---|---|---|
| Mr. Richard A. Dierker | President, CEO & Director | 45 |
| Mr. Lee B. McChesney | CFO & Executive VP | 53 |
| Mr. Patrick D. de Maynadier Esq., J.D. | Executive VP, General Counsel & Secretary | 65 |
| Mr. Michael G. Read | Executive Vice President of International | 50 |
| Mr. Charles R. Raup | Executive VP & President of US Domestic | 57 |
| Mr. Joseph James Longo | VP, Chief Accounting Officer & Corporate Controller | 54 |
| Mr. Carlos G. Linares | Executive VP, CTO & Global New Product Innovation | 61 |
| Ms. Stacey Ramstedt | Senior VP & Chief Marketing Officer | - |
| Ms. Rene M. Hemsey | Executive VP & Chief Human Resources Officer | 57 |
| Mr. Brian Buchert | Executive VP of Strategy, M&A and Business Partnerships | - |
Risque d'audit
4
Risque du conseil
4
Risque de rémunération
2
Risque droits des actionnaires
5
Partie 2 · Le prix et le moment d'entrer
Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.
Documents
- Voir le document
Rapport annuel (10-K)
Un aperçu annuel de l'activité, des résultats financiers et des risques de l'entreprise.
Déposé le 2026-02-12
- Voir le document
Rapport trimestriel (10-Q)
Une mise à jour de la performance financière des trois derniers mois.
Déposé le 2026-07-31
- Voir le document
Rapport d'événement important (8-K)
Un avis concernant un événement important, comme un changement de direction ou une annonce majeure.
Déposé le 2026-07-31
via SEC EDGAR
Historique des résultats
via SEC EDGAR
Latest News
Recent headlines for CHD, sourced from Markets Gazette.